Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01045733 · ClinicalTrials.gov registry record · NA

A Comparison of Corneal Aberrations in Subjects With Contralateral AcrySof IQ Toric Intraocular Lens (IOL) and AcrySof IQ IOL With Limbal Relaxing Incision (LRI)

A NA study of Cataract and Astigmatism, sponsored by Alcon Research.

Completed
Registry status
NA
Development phase
70
Enrollment target
1
Study location

NCT01045733 is a NA study of Cataract and Astigmatism that has completed, run by Alcon Research. The registered enrollment target is 70 participants, below the 228-participant average among 83 other Cataract trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01045733, a NA study of Cataract and Astigmatism, has completed, sponsored by Alcon Research.

COMPLETED
Registry status
NA
Development phase
70 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study was to evaluate and compare postoperative corneal aberrations and visual parameters in patients contralaterally implanted with an AcrySof IQ Toric intraocular lens (IOL) and AcrySof IQ Aspheric IOL with concomitant limbal relaxing incision.

Conditions Studied

Interventions

  • DEVICE AcrySof IQ Toric IOL
  • DEVICE AcrySof IQ Aspheric IOL
  • PROCEDURE Limbal Relaxing Incision (LRI)

Study Locations (1)

Texas

  • Contact Alcon Call Center for Trial Locations - Fort Worth

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2009-12
Est. Completion 2011-05
Phase NA

Sponsor

Alcon Research

275 total trials

What the Registry Record Tells You About NCT01045733

The ClinicalTrials.gov registry entry for NCT01045733 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 228-participant average among 83 other Cataract trials with a reported enrollment target (69% lower). The listed sponsor is Alcon Research, which has 275 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Cataract appearing as the primary indexed condition, and to 3 interventions - of which AcrySof IQ Toric IOL is the first listed.

NCT01045733 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT01045733 about?

NCT01045733 is a clinical study titled "A Comparison of Corneal Aberrations in Subjects With Contralateral AcrySof IQ Toric Intraocular Lens (IOL) and AcrySof IQ IOL With Limbal Relaxing Incision (LRI)". The purpose of this study was to evaluate and compare postoperative corneal aberrations and visual parameters in patients contralaterally implanted with an AcrySof IQ Toric intraocular lens (IOL) and AcrySof IQ Aspheric IOL with concomitant limbal relaxing incision.

What is the current status of trial NCT01045733?

This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2009-12. Estimated completion is 2011-05.

What conditions does trial NCT01045733 study?

This clinical trial studies the following conditions: Cataract, Astigmatism.

What interventions are being tested in trial NCT01045733?

The interventions under investigation include: AcrySof IQ Toric IOL (DEVICE), AcrySof IQ Aspheric IOL (DEVICE), Limbal Relaxing Incision (LRI) (PROCEDURE).

Who is sponsoring clinical trial NCT01045733?

This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01045733 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cataract

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.